Gregory Dietrich, MD
Orthopaedic Surgery of the Spine · Lewiston, IDNPI 1306831698
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $38,943 of the $41,537 with a category attached, or 93.8%. Renovis Surgical Technologies, Inc. accounts for 68.8% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $30,134 and has fallen 99.5% since, to $140 in 2025.
Across 41 payments — averaging $1013.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Renovis Surgical Technologies, Inc.$29K
- Kyocera Medical Technologies, Inc.$10K
- Globus Medical$2K
- Johnson & Johnson$715
- Stryker$153
- Ferring Pharmaceuticals Inc.$61
- plus $150 from 6 others
What the payments were for
- Royalty or licence$38,94394%
- Travel & lodging$1,0493%
- Food & beverage$1,5464%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Renovis Surgical Technologies, Inc. | 1 | $28,580 |
| Kyocera Medical Technologies, Inc. | 3 | $10,363 |
| Globus Medical(2 entities) | 11 | $1,516 |
| Johnson & Johnson | 10 | $715 |
| Stryker | 7 | $153 |
| Ferring Pharmaceuticals Inc. | 3 | $61 |
| Sanara Medtech Inc. | 1 | $35 |
| Seaspine Orthopedics Corporation | 1 | $33 |
| Sawtooth Surgical Solutions Inc | 1 | $32 |
| Heron Therapeutics, Inc. | 1 | $23 |
| Summit Surgical Corp. | 1 | $17 |
| Brainlab, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few orthopaedic surgery of the spine providers in Idahoto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 76 | $749 |
| Methylprednisolone | 33 | $193 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 11 | $129 |
| Methocarbamol | 35 | $113 |
| Hydromorphone Hcl | 13 | $113 |
| Tramadol Hcl | 32 | $103 |
| Ondansetron OdtOndansetron | 11 | $90 |
| Oxycodone Hcl | 12 | $58 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery of the spine in Lewiston
- Roland KentPost Falls$1.1M
- Samuel JorgensonMeridian$381K
- Daniel BlizzardPost Falls$269K
- David GlassmanPost Falls$77K
- William BradleyMeridian$70K
- Stephen HansenPocatello$15K
- David VerstHailey$10K
- Mark WeightIdaho Falls$8K
- Benjamin BlairPocatello$1K
- Lynn StrombergIdaho Falls$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.